Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Asmaa M Zahran, Amal Rayan, Hussein Fakhry, Alia M Attia, Ahmed M Ashmawy, Ahmed Soliman, Azza Elkady & Helal F Hetta. (2019) Pretreatment detection of circulating and tissue CD133+ CD44+ cancer stem cells as a prognostic factor affecting the outcomes in Egyptian patients with colorectal cancer. Cancer Management and Research 11, pages 1237-1248.
Read now
Read now
Claudia Peitzsch, Ina Kurth, Nadja Ebert, Anna Dubrovska & Michael Baumann. (2019) Cancer stem cells in radiation response: current views and future perspectives in radiation oncology. International Journal of Radiation Biology 95:7, pages 900-911.
Read now
Read now
Rodney Luwor, Andrew P. Morokoff, Stephanie Amiridis, Giovanna D’Abaco, Lucia Paradiso, Stanley S. Stylli, Hong P. T. Nguyen, Mark Tarleton, Kelly A. Young, Terence J. O’Brien, Phillip J. Robinson, Megan Chircop, Adam McCluskey & Nigel C. Jones. (2019) Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma. Cancer Investigation 37:3, pages 144-155.
Read now
Read now
Fang-bo Cui, Qin Liu, Ru-Tian Li, Jie Shen, Pu-yuan Wu, Li-Xia Yu, Wen-jing Hu, Feng-lei Wu, Chun-Ping Jiang, Guo-feng Yue, Xiao-Ping Qian, Xi-Qun Jiang & Bao-Rui Liu. (2014) Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells. International Journal of Nanomedicine 9, pages 2345-2358.
Read now
Read now
Niamh McDermott, Armelle Meunier, Thomas H. Lynch, Donal Hollywood & Laure Marignol. (2014) Isogenic radiation resistant cell lines: Development and validation strategies. International Journal of Radiation Biology 90:2, pages 115-126.
Read now
Read now
Mélanie Marie, Sophia Hafner, Sandra Moratille, Pierre Vaigot, Solène Mine, Odile Rigaud & Michèle T. Martin. (2012) FGF2 mediates DNA repair in epidermoid carcinoma cells exposed to ionizing radiation. International Journal of Radiation Biology 88:10, pages 688-693.
Read now
Read now
Articles from other publishers (61)
Tingting Yao, Yao Yao, Zhiliao Chen, Yongpai Peng, Guanglei Zhong, Chunxian Huang, Jing Li & Ruixin Li. (2022) CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance. Cancer Cell International 22:1.
Crossref
Crossref
Berit Kummer, Steffen Löck, Kristin Gurtner, Nadine Hermann, Ala Yaromina, Wolfgang Eicheler, Michael Baumann, Mechthild Krause & Christina Jentsch. (2021) Value of functional in-vivo endpoints in preclinical radiation research. Radiotherapy and Oncology 158, pages 155-161.
Crossref
Crossref
María Auxiliadora Olivares-Urbano, Carmen Griñán-Lisón, Juan Antonio Marchal & María Isabel Núñez. (2020) CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer. Cells 9:7, pages 1651.
Crossref
Crossref
Sanaa A El-Benhawy, Heba G El-Sheredy, Heba B Ghanem & Amira A Abo El-Soud. (2020) Berberine can amplify cytotoxic effect of radiotherapy by targeting cancer stem cells. Breast Cancer Management 9:2.
Crossref
Crossref
Christoph Reinhold Arnold, Julian Mangesius, Ira-Ida Skvortsova & Ute Ganswindt. (2020) The Role of Cancer Stem Cells in Radiation Resistance. Frontiers in Oncology 10.
Crossref
Crossref
R. Joyce, G. O’Boyle, R. L. McDermott & C. Small. (2019) The role of tumour volume as a prognostic factor in non-small cell lung cancer (NSCLC) patients treated with definitive radiotherapy. Journal of Radiotherapy in Practice 18:03, pages 218-224.
Crossref
Crossref
Niyati Sudhalkar, Nidul P. Rathod, Ashwathi Mathews, Supriya Chopra, Harshini Sriram, Shyam K. Shrivastava & Jayant S. Goda. (2018) Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer. CANCER REPORTS 2:2, pages e1144.
Crossref
Crossref
Brita Singers Sørensen, Christian Nicolaj Andreassen & Jan Alsner. 2019. Radiation Oncology. Radiation Oncology
1
20
.
C.N. Andreassen, J.G. Eriksen, K. Jensen, C.R. Hansen, B.S. Sørensen, P. Lassen, J. Alsner, L.M.H. Schack, J. Overgaard & C. Grau. (2018) IMRT – Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer. Oral Oncology 86, pages 91-99.
Crossref
Crossref
Martina Intartaglia, Rosalaura Sabetta, Monica Gargiulo, Giovanna Roncador, Federica Zito Marino & Renato Franco. 2018. Cancer Stem Cells. Cancer Stem Cells
195
211
.
Hamidreza Badri & Kevin Leder. (2016) Optimal treatment and stochastic modeling of heterogeneous tumors. Biology Direct 11:1.
Crossref
Crossref
Fengsheng Li, Kunming Zhou, Ling Gao, Bin Zhang, Wei Li, Weijuan Yan, Xiujun Song, Huijie Yu, Sinian Wang, Nan Yu & Qisheng Jiang. (2016) Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistance. Oncology Letters 12:5, pages 3059-3065.
Crossref
Crossref
N. McDermott, A. Meunier, B. Mooney, G. Nortey, C. Hernandez, S. Hurley, N. Lynam-Lennon, S. H. Barsoom, K. J. Bowman, B. Marples, G. D. D. Jones & L. Marignol. (2016) Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells. Scientific Reports 6:1.
Crossref
Crossref
Ines Lohse, Joanna Rasowski, Pinjiang Cao, Melania Pintilie, Trevor Do, Ming-Sound Tsao, Richard P. Hill & David W. Hedley. (2016) Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302. Oncotarget 7:23, pages 33571-33580.
Crossref
Crossref
Annett Linge, Steffen Löck, Volker Gudziol, Alexander Nowak, Fabian Lohaus, Cläre von Neubeck, Martin Jütz, Amir Abdollahi, Jürgen Debus, Inge Tinhofer, Volker Budach, Ali Sak, Martin Stuschke, Panagiotis Balermpas, Claus Rödel, Melanie Avlar, Anca-Ligia Grosu, Christine Bayer, Claus Belka, Steffi Pigorsch, Stephanie E. Combs, Stefan Welz, Daniel Zips, Frank Buchholz, Daniela E. Aust, Gustavo B. Baretton, Howard D. Thames, Anna Dubrovska, Jan Alsner, Jens Overgaard, Michael Baumann & Mechthild Krause. (2016) Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG. Clinical Cancer Research 22:11, pages 2639-2649.
Crossref
Crossref
Annett Linge, Anna Dubrovska, Michael Baumann & Mechthild Krause. 2016. Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment. Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment
43
74
.
R. Bütof & M. Krause. (2015) TumorvolumenbestimmungTumor volume determination. Der Onkologe 21:5, pages 382-387.
Crossref
Crossref
Kristin Gurtner, Nadja Ebert, Dorothee Pfitzmann, Wolfgang Eicheler, Daniel Zips, Michael Baumann & Mechthild Krause. (2014) Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts. Radiation Oncology 9:1.
Crossref
Crossref
Kanako Azuma, Satoshi Serada, Shinji Takamatsu, Naoko Terao, Shunsaku Takeishi, Yoshihiro Kamada, Tetsuji Naka & Eiji Miyoshi. (2014) Identification of Sialylated Glycoproteins in Doxorubicin-Treated Hepatoma Cells with Glycoproteomic Analyses. Journal of Proteome Research 13:11, pages 4869-4877.
Crossref
Crossref
Victoria Anastasia Belle, Niamh McDermott, Armelle Meunier & Laure Marignol. (2014) NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer. Nature Reviews Urology 11:9, pages 499-507.
Crossref
Crossref
Liangfang Shen, Xinqiong Huang, Xiaoxue Xie, Juan Su, Jun Yuan & Xiang Chen. (2014) High Expression of SOX2 and OCT4 Indicates Radiation Resistance and an Independent Negative Prognosis in Cervical Squamous Cell Carcinoma. Journal of Histochemistry & Cytochemistry 62:7, pages 499-509.
Crossref
Crossref
Andrew Dhawan, Mohammad Kohandel, Richard Hill & Sivabal Sivaloganathan. (2014) Tumour Control Probability in Cancer Stem Cells Hypothesis. PLoS ONE 9:5, pages e96093.
Crossref
Crossref
Sara Häggblad Sahlberg, Diana Spiegelberg, Bengt Glimelius, Bo Stenerlöw & Marika Nestor. (2014) Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells. PLoS ONE 9:4, pages e94621.
Crossref
Crossref
I. Kurth, C. Peitzsch, M. Baumann & A. Dubrovska. 2014. Cancer Stem Cells. Cancer Stem Cells
473
491
.
RG Bristow, A Berlin & A Dal Pra. (2014) An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy. The British Journal of Radiology 87:1035, pages 20130753.
Crossref
Crossref
Lydia Koi, Ralf Bergmann, Kerstin Brüchner, Jens Pietzsch, Hans-Jürgen Pietzsch, Mechthild Krause, Jörg Steinbach, Daniel Zips & Michael Baumann. (2014) Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential. Radiotherapy and Oncology 110:2, pages 362-369.
Crossref
Crossref
Wu-Zhe Zhang. (2014) Simultaneous modulated accelerated radiation therapy for esophageal cancer: A feasibility study. World Journal of Gastroenterology 20:38, pages 13973.
Crossref
Crossref
Y. Hirota, S.-I. Masunaga, N. Kondo, S. Kawabata, H. Hirakawa, H. Yajima, A. Fujimori, K. Ono, T. Kuroiwa & S.-I. Miyatake. (2013) High linear-energy-transfer radiation can overcome radioresistance of glioma stem-like cells to low linear-energy-transfer radiation. Journal of Radiation Research 55:1, pages 75-83.
Crossref
Crossref
Hatim Fakir, Lynn Hlatky, Huamin Li & Rainer Sachs. (2013) Repopulation of interacting tumor cells during fractionated radiotherapy: Stochastic modeling of the tumor control probability. Medical Physics 40:12, pages 121716.
Crossref
Crossref
Michael Baumann, Stephan Bodis, Ekkehard Dikomey, Albert van der Kogel, Jens Overgaard, Hans Peter Rodemann & Bradly Wouters. (2013) Molecular radiation biology/oncology at its best: Cutting edge research presented at the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology. Radiotherapy and Oncology 108:3, pages 357-361.
Crossref
Crossref
Ulrike Koch, Katharina Höhne, Cläre von Neubeck, Howard D. Thames, Ala Yaromina, Jochen Dahm-Daphi, Michael Baumann & Mechthild Krause. (2013) Residual γH2AX foci predict local tumour control after radiotherapy. Radiotherapy and Oncology 108:3, pages 434-439.
Crossref
Crossref
Rebecca Bütof, Anna Dubrovska & Michael Baumann. (2013) Clinical perspectives of cancer stem cell research in radiation oncology. Radiotherapy and Oncology 108:3, pages 388-396.
Crossref
Crossref
Tareq A Juratli, Gabriele Schackert & Dietmar Krex. (2013) Current status of local therapy in malignant gliomas — A clinical review of three selected approaches. Pharmacology & Therapeutics 139:3, pages 341-358.
Crossref
Crossref
S.E. Combs & J. Debus. (2013) Translationale UroradioonkologieTranslational uroradio-oncology. Der Urologe 52:9, pages 1276-1282.
Crossref
Crossref
Lu Han, Sanjun Shi, Tao Gong, Zhirong Zhang & Xun Sun. (2013) Cancer stem cells: therapeutic implications and perspectives in cancer therapy. Acta Pharmaceutica Sinica B 3:2, pages 65-75.
Crossref
Crossref
Rebecca Bütof & Michael Baumann. (2013) Time in radiation oncology – Keep it short!. Radiotherapy and Oncology 106:3, pages 271-275.
Crossref
Crossref
Philipp Grosse‐Gehling, Christine A Fargeas, Claudia Dittfeld, Yvette Garbe, Malcolm R Alison, Denis Corbeil & Leoni A Kunz‐Schughart. (2012) CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. The Journal of Pathology 229:3, pages 355-378.
Crossref
Crossref
Clemens Seidel, Christine Lautenschläger, Jürgen Dunst & Arndt-Christian Müller. (2012) Factors influencing heterogeneity of radiation-induced DNA-damage measured by the alkaline comet assay. Radiation Oncology 7:1.
Crossref
Crossref
Qibin Fu, Yi Quan, Weikang Wang, Tao Mei, Jingwen Wu, Jia Li, Gen Yang, Xiaotang Ren, Jianming Xue & Yugang Wang. (2012) Response of cancer stem-like cells and non-stem cancer cells to proton and γ-ray irradiation. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms 286, pages 346-350.
Crossref
Crossref
Rikke Leth-Larsen, Mikkel G. Terp, Anne G. Christensen, Daniel Elias, Thorsten Kühlwein, Ole N. Jensen, Ole W. Petersen & Henrik J. Ditzel. (2012) Functional Heterogeneity within the CD44 High Human Breast Cancer Stem Cell-Like Compartment Reveals a Gene Signature Predictive of Distant Metastasis. Molecular Medicine 18:7, pages 1109-1121.
Crossref
Crossref
Thomas B. Brunner, Leoni A. Kunz-Schughart, Philipp Grosse-Gehling & Michael Baumann. (2012) Cancer Stem Cells as a Predictive Factor in Radiotherapy. Seminars in Radiation Oncology 22:2, pages 151-174.
Crossref
Crossref
Adrian C. Begg. (2012) Predicting Recurrence After Radiotherapy in Head and Neck Cancer. Seminars in Radiation Oncology 22:2, pages 108-118.
Crossref
Crossref
Ala Yaromina, Mechthild Krause & Michael Baumann. (2012) Individualization of cancer treatment from radiotherapy perspective. Molecular Oncology 6:2, pages 211-221.
Crossref
Crossref
Kristin Gurtner, Franziska Hessel, Wolfgang Eicheler, Annegret Dörfler, Daniel Zips, Karl-Heinz Heider, Mechthild Krause & Michael Baumann. (2012) Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo. Radiotherapy and Oncology 102:3, pages 444-449.
Crossref
Crossref
Mechthild Krause, Ala Yaromina, Wolfgang Eicheler, Ulrike Koch & Michael Baumann. (2011) Cancer Stem Cells: Targets and Potential Biomarkers for Radiotherapy. Clinical Cancer Research 17:23, pages 7224-7229.
Crossref
Crossref
Alexander Chi, Wolfgang A. Tomé, Jack Fowler, Ritsuko Komaki, Nam P. Nguyen, Minesh P. Mehta & James S. Welsh. (2011) Stereotactic Body Radiation Therapy in Non–Small-Cell Lung Cancer. American Journal of Clinical Oncology 34:4, pages 432-441.
Crossref
Crossref
Naomi L. Dunning, Stéphanie A. Laversin, Amanda K. Miles & Robert C. Rees. (2011) Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?. Cancer Immunology, Immunotherapy 60:8, pages 1181-1193.
Crossref
Crossref
Julia Mihatsch, Mahmoud Toulany, Petra M. Bareiss, Sabrina Grimm, Claudia Lengerke, Rainer Kehlbach & H. Peter Rodemann. (2011) Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro. Radiotherapy and Oncology 99:3, pages 300-306.
Crossref
Crossref
C. Petersen & E. Dikomey. (2011) StrahlenresistenzforschungRadioresistance research. Forum.
Crossref
Crossref
Ilaria Chiodi, Cristina Belgiovine, Francesca Donà, A. Ivana Scovassi & Chiara Mondello. (2011) Drug Treatment of Cancer Cell Lines: A Way to Select for Cancer Stem Cells?. Cancers 3:1, pages 1111-1128.
Crossref
Crossref
Sara Raquel Martins Neves & Celia Maria Freitas Gomes. (2011) Identification of cancer stem-like cells in osteosarcoma: Implications in radioresistance. Identification of cancer stem-like cells in osteosarcoma: Implications in radioresistance.
Michael Baumann & Mechthild Krause. (2010) CD44: A Cancer Stem Cell–Related Biomarker with Predictive Potential for Radiotherapy. Clinical Cancer Research 16:21, pages 5091-5093.
Crossref
Crossref
Monique C. de Jong, Jimmy Pramana, Jacqueline E. van der Wal, Martin Lacko, Carine J. Peutz-Kootstra, Jos M. de Jong, Robert P. Takes, Johannes H. Kaanders, Bernard F. van der Laan, Jasper Wachters, Jeroen C. Jansen, Coen R. Rasch, Marie-Louise F. van Velthuysen, Reidar Grénman, Frank J. Hoebers, Ed Schuuring, Michiel W. van den Brekel & Adrian C. Begg. (2010) CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer. Clinical Cancer Research 16:21, pages 5329-5338.
Crossref
Crossref
Michael Baumann, Tobias Hölscher & Jim Denham. (2010) Fractionation in prostate cancer – Is it time after all?. Radiotherapy and Oncology 96:1, pages 1-5.
Crossref
Crossref
Huan He, Carol L. Nilsson, Mark R. Emmett, Alan G. Marshall, Roger A. Kroes, Joseph R. Moskal, Yongjie Ji, Howard Colman, Waldemar Priebe, Frederick F. Lang & Charles A. Conrad. (2010) Glycomic and Transcriptomic Response of GSC11 Glioblastoma Stem Cells to STAT3 Phosphorylation Inhibition and Serum-Induced Differentiation. Journal of Proteome Research 9:5, pages 2098-2108.
Crossref
Crossref
Ulrike Koch, Mechthild Krause & Michael Baumann. (2010) Cancer stem cells at the crossroads of current cancer therapy failures—Radiation oncology perspective. Seminars in Cancer Biology 20:2, pages 116-124.
Crossref
Crossref
Bisrat G. Debeb, Wei Xu, Henry Mok, Li Li, Fredika Robertson, Naoto T. Ueno, Jim Reuben, Anthony Lucci, Massimo Cristofanilli & Wendy A. Woodward. (2010) Differential Radiosensitizing Effect of Valproic Acid in Differentiation Versus Self-Renewal Promoting Culture Conditions. International Journal of Radiation Oncology*Biology*Physics 76:3, pages 889-895.
Crossref
Crossref
C. Maenhaut, J.E. Dumont, P.P. Roger & W.C.G. van Staveren. (2010) Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis. Carcinogenesis 31:2, pages 149-158.
Crossref
Crossref
Priya R Baraniak & Todd C McDevitt. (2010) Stem cell paracrine actions and tissue regeneration. Regenerative Medicine 5:1, pages 121-143.
Crossref
Crossref
Alexander Chi, Zhongxing Liao, Nam P. Nguyen, Jiahong Xu, Baldassarre Stea & Ritsuko Komaki. (2010) Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications. Radiotherapy and Oncology 94:1, pages 1-11.
Crossref
Crossref
Michael Baumann & Mechthild Krause. 2009. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies
323
334
.